gadobutrol
NDC 70436-213, gadobutrol, injection, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-213
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217480
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GADOBUTROL604.72 mg/mL
Pharmacologic classes
Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-213-82 | 70436021382 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-213-82) / 10 mL in 1 VIAL, SINGLE-DOSE (70436-213-33) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/832e0ae1-4fe1-4dff-9978-c9200bcebb55Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70436-213
Use it
Look up 70436-213 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.